About RetinEdge
RetinEdge is a Healthcare company based in Hyderabad (India) founded in 2021. AI diagnostic tool for detecting eye diseases like diabetic retinopathy using retinal images. It operates on a SaaS model in Healthcare and Technology sectors. The company has 1 employees. Its Indian entity Amberflux Edgeai Private Limited reported revenue of ₹1.50 Cr. RetinEdge offers products and services including retinEdge. Its focus areas include Medical Diagnostics, Chronic Disease Management, Diabetic Complications and AI Diagnostics.
Company details
retinEdge is an artificial intelligence-based software designed to identify diabetic retinopathy and other eye diseases through analysis of retinal images. It allows non-experts to upload images for instant detection and grading, facilitating early intervention to prevent vision loss. The tool operates on mobile, laptops, or cloud platforms and can integrate with hospital systems. It targets medical practitioners and clinics, promoting accessible diagnostics amid the growing risk to over 500 million people with diabetes.
- Headquarters Hyderabad, India
- Employees 1
- SectorsHealthcareTechnology
- Email••••••••
- Website retinedge.com
- Legal Name Amberflux Edgeai Private Limited
- Date of Incorporation 08 Aug, 2020
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1.50 Cr
FY 2025 · +2155% YoY
- Net Profit₹21.3 Lakh
FY 2025 · 14% margin
- EBITDA₹29.8 Lakh
FY 2025 · 20% margin
- Employee Count1
Associated legal entities of RetinEdge
RetinEdge operates through Amberflux Edgeai Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Amberflux Edgeai Private Limited CIN U72900TG2020PTC142618 | Active | 08 Aug 2020 | Hyderabad, Telangana | ₹1.5 Cr | 3 | View details |
Products & Services of RetinEdge
RetinEdge offers a comprehensive portfolio of products and services, including retinEdge.
AI software for detecting diabetic retinopathy from retinal images instantly.
Board of directors of Amberflux Edgeai Private Limited (RetinEdge)
Amberflux Edgeai Private Limited is the primary company behind RetinEdge. The board of Amberflux Edgeai Private Limited currently have 3 directors; the longest-serving is Goparaju Vinulata, appointed in 2020.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Goparaju Vinulata DIN 00872904 | Director | 08 Aug 2020 | 6 yrs 3 mo | Amberflux Edgeai Private Limited |
| Goparaju Muralidhar DIN 00872857 | Managing Director | 08 Aug 2020 | 6 yrs 3 mo | Amberflux Edgeai Private Limited |
| Raghavendra Rao Gudipudi DIN 08826369 | Director | 08 Aug 2020 | 6 yrs 3 mo | Amberflux Edgeai Private Limited |
Financials of RetinEdge
Figures of Amberflux Edgeai Private Limited, the primary company behind RetinEdge, for FY 2025. Revenue was ₹1.50 Cr (+2155% year on year). Net profit was ₹21.3 Lakh (14% margin). EBITDA was ₹29.8 Lakh (20% margin). Revenue has grown at a compounded annual rate of +1859% over three years.
- ₹1.50 CrRevenue · FY 2025 · +2155% YoY
- ₹21.3 LakhNet profit · 14% margin
- ₹29.8 LakhEBITDA · 20% margin
- ₹20 LakhPaid-up capital
- +1859%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Amberflux Edgeai Private Limited are on its company page.
Detailed financial statements for RetinEdge
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about RetinEdge
RetinEdge was founded in 2021.
RetinEdge is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
RetinEdge has 1 employees.
The primary company behind RetinEdge, Amberflux Edgeai Private Limited, reported revenue of ₹1.50 Cr for FY 2025, up 2155% year on year.
retinEdge is an artificial intelligence-based software designed to identify diabetic retinopathy and other eye diseases through analysis of retinal images. It allows non-experts to upload images for instant detection and grading, facilitating early intervention to prevent vision loss. The tool operates on mobile, laptops, or cloud platforms and can integrate with hospital systems. It targets medical practitioners and clinics, promoting accessible diagnostics amid the growing risk to over 500 million people with diabetes.
RetinEdge offers retinEdge.
RetinEdge operates through Amberflux Edgeai Private Limited.
The legal entities of RetinEdge currently have 3 directors, including Goparaju Vinulata, Goparaju Muralidhar, Raghavendra Rao Gudipudi.